G1 Therapeutics
Latest round
- Series C
Last raised
- Apr 2016
Total raised
- $93M
Investors
- 13
About G1 Therapeutics
Founded in 2008 and based in North Carolina, US, G1 Therapeutics, Inc. is a biopharmaceutical company that develops and commercializes small-molecule therapeutics for the treatment of patients with cancer.
Who invested in G1 Therapeutics
13 investors across 4 rounds
See all investors in G1 Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about G1 Therapeutics
Who invested in G1 Therapeutics?
G1 Therapeutics has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has G1 Therapeutics raised?
G1 Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did G1 Therapeutics last raise money?
G1 Therapeutics's most recent round on record is a Series C, in Apr 2016.
What does G1 Therapeutics do?
Founded in 2008 and based in North Carolina, US, G1 Therapeutics, Inc.
Where is G1 Therapeutics headquartered?
G1 Therapeutics is headquartered in US.
Which VCs invest in companies like G1 Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at G1 Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like G1 Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.